An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism

An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism

Qingjuan Ren,1,2 Shuchun Chen,1,3 Xing Chen,1 Shu Niu,4 Lin Yue,5 Xiaoyu Pan,1 Zelin Li,1 Xiaoyi Chen1 1Department of Internal Medicine, Hebei Medical University, Shijiazhuang, 050000, People’s Republic of China; 2Department of Geriatrics, Shijiazhuang People’s Hospital, Shijiazhuang, 050000, People...

Full description

Bibliographic Details
Main Authors: Ren Q, Chen S, Chen X, Niu S, Yue L, Pan X, Li Z
Format: Article
Language:English
Published: Dove Medical Press 2022-10-01
Series:Drug Design, Development and Therapy
Subjects:
sarcopenic obesity
sarcopenia
glucagon-like peptide-1 receptor agonists
semaglutide
metabonomics.
Online Access:https://www.dovepress.com/an-effective-glucagon-like-peptide-1-receptor-agonists-semaglutide-imp-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/an-effective-glucagon-like-peptide-1-receptor-agonists-semaglutide-imp-peer-reviewed-fulltext-article-DDDT

Similar Items